СИБР (хирургическое лечение и профилактика)

256. Romics, L. Selective priming to Toll-like receptor 4 (TLR4), not TLR2, ligands by P. acnes involves up-regulation of MD-2 in mice / L. Romics, A. Dolganiuc, K. Kodys et al. // Hepatology. 2004; 40: 555–564 [PMID: 15349893 DOI: 10.1002 / hep.20350]

257. Gustot, T. Differential liver sensitization to toll-like receptor pathways in mice with alcoholic fatty liver / T. Gustot, A. Lemmers, C. Moreno et al. // Hepatology. 2006; 43: 989–1000 [PMID: 16628628 DOI: 10.1002 / hep.21138]

258. Purohit, V. Alcohol, intestinal bacterial growth, intestinal permeability to endotoxin, and medical consequences: summary of a symposium / V. Purohit, J. C. Bode, C. Bode // Alcohol. 2008; 42: 349–361 [PMID: 18504085 DOI: 10.1016 / j.alcohol.2008.03.131]

259. Bjarnason, I. The leaky gut of alcoholism: possible route of entry for toxic compounds / I. Bjarnason, T. J. Peters, R. J. Wise et al. // Lancet. 1984; 1: 179–182 [PMID: 6141332]

260. Keshavarzian, A. The differing effects of acute and chronic alcohol on gastric and intestinal permeability / A. Keshavarzian, J. Z. Fields, J. Vaeth et al. // Am J Gastroenterol. 1994; 89: 2205–2211 [PMID: 7977243]

261. Keshavarzian, A. Leaky gut in alcoholic cirrhosis: a possible mechanism for alcohol-induced liver damage / A. Keshavarzian, E. W. Holmes, M. Patel et al. // Am J Gastroenterol. 1999; 94: 200–207 [PMID: 9934756 DOI: 10.1111 / j.1572–0241.1999.00797.x]

262. Parlesak, A. Increased intestinal permeability to macromolecules and endotoxemia in patients with chronic alcohol abuse in different stages of alcohol-induced liver disease / A. Parlesak, C. Schäfer, T. Schütz et al. // J Hepatol. 2000; 32: 742–747 [PMID: 10845660]

263. Enomoto, N. Thalidomide prevents alcoholic liver injury in rats through suppression of Kupffer cell sensitization and TNF-alpha production / N. Enomoto, Y. Takei, M. Hirose et al. // Gastroenterology. 2002; 123: 291–300 [PMID: 12105857]

264. Forsyth, C. B. Lactobacillus GG treatment ameliorates alcohol-induced intestinal oxidative stress, gut leakiness, and liver injury in a rat model of alcoholic steatohepatitis / C. B. Forsyth, A. Farhadi, S. M. Jakate et al. // Alcohol. 2009; 43: 163–172 [PMID: 19251117 DOI: 10.1016 / j.alcohol.2008.12.009]

265. Mathurin, P. Exacerbation of alcoholic liver injury by enteral endotoxin in rats / P. Mathurin, Q. G. Deng, A. Keshavarzian et al. // Hepatology. 2000; 32: 1008–1017 [PMID: 11050051 DOI: 10.1053 / jhep.2000.19621]

266. Keshavarzian, A. Preventing gut leakiness by oats supplementation ameliorates alcohol-induced liver damage in rats / A. Keshavarzian, S. Choudhary, E. W. Holmes et al. / J Pharmacol Exp Ther. 2001; 299: 442–448 [PMID: 11602653]

267. Keshavarzian, A. Evidence that chronic alcohol exposure promotes intestinal oxidative stress, intestinal hyperpermeability and endotoxemia prior to development of alcoholic steatohepatitis in rats / A. Keshavarzian, A. Farhadi, C. B. Forsyth et al. // J Hepatol. 2009; 50: 538–547 [PMID: 19155080 DOI: 10.1016 / j.jhep.2008.10.028

268. Lambert, J. C. Prevention of alterations in intestinal permeability is involved in zinc inhibition of acute ethanol-induced liver damage in mice / J. C. Lambert, Z. Zhou, L. Wang et al. // J Pharmacol Exp Ther2003; 305: 880–886 [PMID: 12626662 DOI: 10.1124 / jpet.102.047852]

269. Harnisch, J. P. Diphtheria among alcoholic urban adults. A decade of experience in Seattle / J. P. Harnisch, E. Tronca // Ann Intern Med. 1989; 111: 71–82 [PMID: 2472081]

270. Cericco, M. Corynebacterium xerosis endocarditis associated with alcoholic cirrhosis / M. Cericco, F. Iglicki, M. P. Guillaumont et al. // Gastroenterol Clin Biol. 1996; 20: 514 [PMID: 8761156]

271. Salaspuro, V. Ethanol oxidation and acetaldehyde production in vitro by human intestinal strains of Escherichia coli under aerobic, microaerobic, and anaerobic conditions / V. Salaspuro, S. Nyfors, R. Heine et al. // Scand J Gastroenterol. 1999; 34: 967–973 [PMID: 10563665]

272. Tillonen, J. Role of catalase in in vitro acetaldehyde formation by human colonic contents / J. Tillonen, P. Kaihovaara, H. JousimiesSomer et al. // Alcohol Clin Exp Res. 1998; 22: 1113–1119 [PMID: 9726283]

273. DuPont, H. L. Рифаксимин: неабсорбирующийся противомикробный препарат в терапии диареи путешественников / H. L. DuPont, C. D. Ericsson, J. J. Mathewson // Гастроnewsлайн. – 2014. – № 5. – С. 5–10.

274. Corazza, G. R. Treatment Of functional bowel disoders: is there room for antibiotics? / G. R. Corazza, M. Di Stefauo, C. Sparpignato // Digestion 2006; 73 (Suppl. 1): 38–46.

275. Kerlin, P. Glucose-H2 breath test for small intestinal bacterial overgrowth / P. Kerlin // Gastroenterology. 1990; 98: 253–4.

Глава 3. Этиопатогенез и анализ антибиотикотерапии СИБР в тонкой кишке (В. Л. Мартынов)